| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of Neurology (Drs. Jeon, Zimmerman, and Pevsner and A.E. Purcell) and Neuroscience (Dr. Blue), Kennedy Krieger Institute, and the Departments of Neuroscience (Drs. Jeon, Blue, and Pevsner and A.E. Purcell) and Neurology (Dr. Blue), Johns Hopkins University School of Medicine, Baltimore, MD.
Address correspondence and reprint requests to Dr. J. Pevsner, Department of Neurology, Kennedy Krieger Institute, 707 North Broadway, Baltimore, MD 21205; e-mail: pevsner{at}kennedykrieger.org
Background:— Studies examining the brains of individuals with autism have identified anatomic and pathologic changes in regions such as the cerebellum and hippocampus. Little, if anything, is known, however, about the molecules that are involved in the pathogenesis of this disorder.
Objective:— To identify genes with abnormal expression levels in the cerebella of subjects with autism.
Method:— Brain samples from a total of 10 individuals with autism and 23 matched controls were collected, mainly from the cerebellum. Two cDNA microarray technologies were used to identify genes that were significantly up- or downregulated in autism. The abnormal mRNA or protein levels of several genes identified by microarray analysis were investigated using PCR with reverse transcription and Western blotting. 
-Amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid (AMPA)- and NMDA-type glutamate receptor densities were examined with receptor autoradiography in the cerebellum, caudate-putamen, and prefrontal cortex.
Results:— The mRNA levels of several genes were significantly increased in autism, including excitatory amino acid transporter 1 and glutamate receptor AMPA 1, two members of the glutamate system. Abnormalities in the protein or mRNA levels of several additional molecules in the glutamate system were identified on further analysis, including glutamate receptor binding proteins. AMPA-type glutamate receptor density was decreased in the cerebellum of individuals with autism (p < 0.05).
Conclusions:— Subjects with autism may have specific abnormalities in the AMPA-type glutamate receptors and glutamate transporters in the cerebellum. These abnormalities may be directly involved in the pathogenesis of the disorder.
This article has been cited by other articles:
|
|
 |
|
  J. Kocerha, M. A. Faghihi, M. A. Lopez-Toledano, J. Huang, A. J. Ramsey, M. G. Caron, N. Sales, D. Willoughby, J. Elmen, H. F. Hansen, et al. MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction PNAS, March 3, 2009; 106(9): 3507 - 3512. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Limon, J. M. Reyes-Ruiz, and R. Miledi From the Cover: Microtransplantation of neurotransmitter receptors from postmortem autistic brains to Xenopus oocytes PNAS, August 5, 2008; 105(31): 10973 - 10977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. C. Spitzer A Rosetta stone for analysis of human membrane protein function PNAS, August 5, 2008; 105(31): 10641 - 10642. [Full Text] [PDF]
|
|
|
|
 |
|
 U. Meyer, B. K. Yee, and J. Feldon The Neurodevelopmental Impact of Prenatal Infections at Different Times of Pregnancy: The Earlier the Worse? Neuroscientist, June 1, 2007; 13(3): 241 - 256. [Abstract] [PDF]
|
|
|
|
 |
|
 M. G. Chez, Q. Burton, T. Dowling, M. Chang, P. Khanna, and C. Kramer Memantine as Adjunctive Therapy in Children Diagnosed With Autistic Spectrum Disorders: An Observation of Initial Clinical Response and Maintenance Tolerability J Child Neurol, May 1, 2007; 22(5): 574 - 579. [Abstract] [PDF]
|
|
|
|
 |
|
 L. A. Page, E. Daly, N. Schmitz, A. Simmons, F. Toal, Q. Deeley, F. Ambery, G. M. McAlonan, K. C. Murphy, and D. G. M. Murphy In Vivo 1H-Magnetic Resonance Spectroscopy Study of Amygdala-Hippocampal and Parietal Regions in Autism Am J Psychiatry, December 1, 2006; 163(12): 2189 - 2192. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-l. Xiong, Z.-y. Jin, and A.-l. Li Bioactive Composition of Pig Laryngeal Cartilage Extracts and Their Free Radical-scavenging Activity Food Science and Technology International, October 1, 2006; 12(5): 371 - 377. [Abstract] [PDF]
|
|
|
|
|
|
M. F. Casanova Neuropathological and Genetic Findings in Autism: The Significance of a Putative Minicolumnopathy Neuroscientist, October 1, 2006; 12(5): 435 - 441. [Abstract] [PDF]
|
|
|
|
 |
|
 S. J. M. C. Palmen, H. van Engeland, P. R. Hof, and C. Schmitz Neuropathological findings in autism Brain, December 1, 2004; 127(12): 2572 - 2583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Muhle, S. V. Trentacoste, and I. Rapin The Genetics of Autism Pediatrics, May 1, 2004; 113(5): e472 - e486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F J Serajee, H Zhong, R Nabi, and A H M M. Huq The metabotropic glutamate receptor 8 gene at 7q31: partial duplication and possible association with autism J. Med. Genet., April 1, 2003; 40(4): e42 - 42. [Full Text] [PDF]
|
|
|
|
|
|
G. Allen and E. Courchesne Differential Effects of Developmental Cerebellar Abnormality on Cognitive and Motor Functions in the Cerebellum: An fMRI Study of Autism Am J Psychiatry, February 1, 2003; 160(2): 262 - 273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Shi, S. H. Fatemi, R. W. Sidwell, and P. H. Patterson Maternal Influenza Infection Causes Marked Behavioral and Pharmacological Changes in the Offspring J. Neurosci., January 1, 2003; 23(1): 297 - 302. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
